Post Contraceptive Pills from Mifegyne USA Garners Trust With 99% Success Rate


Posted October 31, 2018 by williamnas36

Post contraceptive pills from Mifegyne USA has won the trust of people and the medical fraternity alike for offering clinically proven 99% success rate
 
FOR IMMEDIATE RELEASE

USA, (27 October 2018) – Mifegyne USA, a leading establishment dedicated to gynecological health has been in news very recently for introducing a whole new generation of post 피임약 that is expected to take the world of unplanned pregnancies by storm. This 100% safe WHO approved solutions have been named among the best 낙태약 that are clinically proven with 99% effectiveness; a figure that many other contraception drugs currently available in the market are yet to match.

Made available in the name of 미프진 oral contraceptive, the solution is currently available to all that are looking for hassle free solutions at very early stages of pregnancy. However, Mifegyne USA has resorted to considerably strict policies as far as purchasing the drugs is concerned. This is mainly about ensuring that the buyers stay safe from risks while maintaining best usage practices.

About Mifegyne USA:
Mifegyne USA is a gynecology / medical clinic that is based in New York, USA and established offices in major cities like Amsterdam, London and San Franciscao. Post contraceptive pills offered by Mifegyne USA have been globally acclaimed for being 100% safe with 99% success rate.

More information on Mifegyne USA and post contraceptive pills from the same is available at https://mifegyneusa.com

Media Contact:
Mifegyne USA
New York
198 West 21th Street, Suite 721
New York NY 10010
Email: [email protected]
Phone: +(880) 101 8990 566
Amsterdam
Spui 21
1012 WX Amsterdam
Email: [email protected]
Phone: +(880) 101 8990 567
London
Houghton Street, Suite 721
London 10010
Email: [email protected]
Phone: +(880) 101 8990 568
San Francisco
2130 Fulton Street
San Francisco, CA 94117
Email: [email protected]
Phone: +(880) 101 8990 569
###
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By mediclinic
Country United States
Categories Business
Last Updated October 31, 2018